Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK2 | P49137 | 18/20 | 0.57 |
| ▸ | CDK1 | P06493 | 16/20 | 0.57 |
| ▸ | PRKD1 | Q15139 | 2/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6649916 | 0.78 | MAPKAPK2 (0.65) | MAPKAPK2CDK1PRKD1KDM4ENPC1 | |
| SCHEMBL6310787 | 0.77 | MAPKAPK2 (0.82) | MAPKAPK2CDK1PRKD1 | |
| SCHEMBL6320092 | 0.77 | MAPKAPK2 (0.82) | MAPKAPK2CDK1PRKD1 | |
| SCHEMBL6312607 | 0.77 | MAPKAPK2 (0.82) | MAPKAPK2CDK1PRKD1 | |
| SCHEMBL9920612 | 0.76 | MAPKAPK2 (0.65) | MAPKAPK2CDK1PRKD1KDM4ENPC1 | |
| SCHEMBL12264785 | 0.73 | ABCB1 (0.48) | MAPKAPK2KDM4ENPC1ALDH1A1MAPT | |
| SCHEMBL6311137 | 0.72 | MAPKAPK2 (1.00) | MAPKAPK2CDK1 | |
| SCHEMBL6314208 | 0.72 | MAPKAPK2 (1.00) | MAPKAPK2CDK1 | |
| SCHEMBL6311690 | 0.72 | MAPKAPK2 (1.00) | MAPKAPK2CDK1 | |
| SCHEMBL6314186 | 0.72 | MAPKAPK2 (0.64) | MAPKAPK2CDK1PRKD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0817635-B1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER LAMBERT CO (US) | 2004-06-16 | — | — | EP | claimed |
| EP-0749434-B1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER LAMBERT CO (US) | 1999-12-15 | — | — | EP | claimed |
| EP-0807015-B1 | PREVENTION OF GROOVE TIP DEFORMATION IN BRIGHTNESS ENHANCEMENT FILM | MINNESOTA MINING & MFG (US) | 1999-08-25 | — | — | EP | claimed |
| EP-0817635-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY LLC (US) | 1998-01-14 | — | — | EP | claimed |
| US-5703069-A | USING (THIA, OXA, OR DI)AZEPINONE COMPOUNDS | WARNER-LAMBERT COMPANY (US) | 1997-12-30 | — | — | US | claimed |
| US-5612330-A | HERPES VIRUS | WARNER-LAMBERT COMPANY (US) | 1997-03-18 | — | — | US | claimed |
| EP-0749434-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1996-12-27 | — | — | EP | claimed |
| US-5565446-A | USEFUL IN TREATMENT OF INFLAMMATORY DISEASES | WARNER-LAMBERT COMPANY (US) | 1996-10-15 | — | — | US | claimed |
| WO-1996029077-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY (US) | 1996-09-26 | — | — | WO | claimed |
| US-5489586-A | BENZOTHIOPHEN, BENZOFURAN AND INDOLE-THIAZEPINONES, OXAZEPINONES AND DIAZEPINONES | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | claimed |
| WO-1995024408-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1995-09-14 | — | — | WO | claimed |
| EP-0817635-B1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER LAMBERT CO (US) | 2004-06-16 | — | — | EP | disclosed |
| EP-0749434-B1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER LAMBERT CO (US) | 1999-12-15 | — | — | EP | disclosed |
| EP-0817635-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY LLC (US) | 1998-01-14 | — | — | EP | disclosed |
| US-5703069-A | USING (THIA, OXA, OR DI)AZEPINONE COMPOUNDS | WARNER-LAMBERT COMPANY (US) | 1997-12-30 | — | — | US | disclosed |
| EP-0749434-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| US-5565446-A | USEFUL IN TREATMENT OF INFLAMMATORY DISEASES | WARNER-LAMBERT COMPANY (US) | 1996-10-15 | — | — | US | disclosed |
| WO-1996029077-A1 | USE OF THIAZEPINE, OXAZEPINE AND DIAZEPINE COUMPOUNDS FOR INHIBITING HIV, HERPESVIRUS AND SUPPRESSING THE IMMUNE SYSTEM | WARNER-LAMBERT COMPANY (US) | 1996-09-26 | — | — | WO | disclosed |
| US-5489586-A | BENZOTHIOPHEN, BENZOFURAN AND INDOLE-THIAZEPINONES, OXAZEPINONES AND DIAZEPINONES | WARNER-LAMBERT COMPANY (US) | 1996-02-06 | — | — | US | disclosed |
| WO-1995024408-A1 | BENZOTHIOPHENE, BENZOFURAN AND INDOLETHIAZEPINONES, OXAZEPINONES AND DIAZEPINONES AS INHIBITORS OF CELL ADHESION AND AS INHIBITORS OF HIV | WARNER-LAMBERT COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |